Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd., commonly referred to as Chia Tai-Tianqing, is a prominent player in the pharmaceutical industry, headquartered in Jiangsu, China. Established in 1994, the company has made significant strides in the development and production of innovative medicines, particularly in the fields of oncology, cardiovascular health, and infectious diseases. With a strong operational presence across various regions in China and a growing international footprint, Chia Tai-Tianqing is recognised for its commitment to quality and research-driven solutions. The company’s core offerings include a diverse range of pharmaceuticals and biopharmaceuticals, distinguished by their efficacy and safety profiles. Notably, Chia Tai-Tianqing has achieved a leading market position, underscored by its robust pipeline of products and strategic partnerships, which enhance its competitive edge in the global pharmaceutical landscape.
How does Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd, headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Jiangsu Chia Tai-Tianqing Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed their initiatives. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Jiangsu Chia Tai-Tianqing to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.